Skip to main content
Erschienen in: Abdominal Radiology 7/2019

06.04.2019 | Review

Hepatic disorders associated with exogenous sex steroids: MR imaging findings

verfasst von: Cathryn L. Hui, Zhen Jiang Lee

Erschienen in: Abdominal Radiology | Ausgabe 7/2019

Einloggen, um Zugang zu erhalten

Abstract

Objective

To describe the MRI findings of the effects of exogenous sex steroids on the liver.

Findings

Estrogens, progesterone and synthetic testosterone are exogenous sex steroids that may result in a variety of liver diseases, including tumour formation and vascular disorders. These hormones are mainly administered in the form of the oral contraceptive pill (OCP) and anabolic steroids. Both are implicated in hepatic adenoma formation. The HNF-1α-mutated and inflammatory adenoma subgroups are more commonly seen in association with the OCP whereas there is an increased incidence of the β-catenin positive subtype with anabolic steroid use. Furthermore, anabolic steroids are associated with hepatocellular carcinoma resulting from malignant transformation of β-catenin positive adenomas. The oral contraceptive pill may also induce vascular disorders within the liver, some of which are related to the prothrombotic effect of the hormones, such as hepatic and portal vein thrombosis. Other hepatic vascular abnormalities resulting from exogenous sex steroids include veno-occlusive disease and peliosis hepatis.
Literatur
1.
Zurück zum Zitat Katabathina VS, Menias CO, Shanbhogue AK, Jagirdar J, Paspulati RM, Prasad SR. Genetics and imaging of hepatocellular adenomas: 2011 update. Radiographics. 2011;31(6):1529–43.CrossRefPubMed Katabathina VS, Menias CO, Shanbhogue AK, Jagirdar J, Paspulati RM, Prasad SR. Genetics and imaging of hepatocellular adenomas: 2011 update. Radiographics. 2011;31(6):1529–43.CrossRefPubMed
2.
Zurück zum Zitat Dhingra S, Fiel MI. Update on the new classification of hepatic adenomas: clinical, molecular, and pathologic characteristics. Arch Pathol Lab Med. 2014;138(8):1090–7.CrossRefPubMed Dhingra S, Fiel MI. Update on the new classification of hepatic adenomas: clinical, molecular, and pathologic characteristics. Arch Pathol Lab Med. 2014;138(8):1090–7.CrossRefPubMed
3.
Zurück zum Zitat McInnes MD, Hibbert RM, Inacio JR, Schieda N. Focal Nodular Hyperplasia and Hepatocellular Adenoma: Accuracy of Gadoxetic Acid-enhanced MR Imaging: A Systematic Review. Radiology. 2015;277(2):413–23.CrossRefPubMed McInnes MD, Hibbert RM, Inacio JR, Schieda N. Focal Nodular Hyperplasia and Hepatocellular Adenoma: Accuracy of Gadoxetic Acid-enhanced MR Imaging: A Systematic Review. Radiology. 2015;277(2):413–23.CrossRefPubMed
4.
Zurück zum Zitat Bioulac-Sage P, Laumonier H, Couchy G, Le Bail B, Sa Cunha A, Rullier A, et al. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Hepatology. 2009;50(2):481–9.CrossRefPubMed Bioulac-Sage P, Laumonier H, Couchy G, Le Bail B, Sa Cunha A, Rullier A, et al. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Hepatology. 2009;50(2):481–9.CrossRefPubMed
5.
Zurück zum Zitat Yoneda N, Matsui O, Kitao A, Kozaka K, Kobayashi S, Sasaki M, et al. Benign Hepatocellular Nodules: Hepatobiliary Phase of Gadoxetic Acid-enhanced MR Imaging Based on Molecular Background. Radiographics. 2016;36(7):2010–27.CrossRefPubMed Yoneda N, Matsui O, Kitao A, Kozaka K, Kobayashi S, Sasaki M, et al. Benign Hepatocellular Nodules: Hepatobiliary Phase of Gadoxetic Acid-enhanced MR Imaging Based on Molecular Background. Radiographics. 2016;36(7):2010–27.CrossRefPubMed
6.
Zurück zum Zitat Rebouissou S, Imbeaud S, Balabaud C, Boulanger V, Bertrand-Michel J, Terce F, et al. HNF1alpha inactivation promotes lipogenesis in human hepatocellular adenoma independently of SREBP-1 and carbohydrate-response element-binding protein (ChREBP) activation. J Biol Chem. 2007;282(19):14437–46.CrossRefPubMed Rebouissou S, Imbeaud S, Balabaud C, Boulanger V, Bertrand-Michel J, Terce F, et al. HNF1alpha inactivation promotes lipogenesis in human hepatocellular adenoma independently of SREBP-1 and carbohydrate-response element-binding protein (ChREBP) activation. J Biol Chem. 2007;282(19):14437–46.CrossRefPubMed
7.
Zurück zum Zitat van Aalten SM, Thomeer MG, Terkivatan T, Dwarkasing RS, Verheij J, de Man RA, et al. Hepatocellular adenomas: correlation of MR imaging findings with pathologic subtype classification. Radiology. 2011;261(1):172–81.CrossRefPubMed van Aalten SM, Thomeer MG, Terkivatan T, Dwarkasing RS, Verheij J, de Man RA, et al. Hepatocellular adenomas: correlation of MR imaging findings with pathologic subtype classification. Radiology. 2011;261(1):172–81.CrossRefPubMed
8.
Zurück zum Zitat Grazioli L, Bondioni MP, Haradome H, Motosugi U, Tinti R, Frittoli B, et al. Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis. Radiology. 2012;262(2):520–9.CrossRefPubMed Grazioli L, Bondioni MP, Haradome H, Motosugi U, Tinti R, Frittoli B, et al. Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis. Radiology. 2012;262(2):520–9.CrossRefPubMed
9.
Zurück zum Zitat Ronot M, Bahrami S, Calderaro J, Valla DC, Bedossa P, Belghiti J, et al. Hepatocellular adenomas: accuracy of magnetic resonance imaging and liver biopsy in subtype classification. Hepatology. 2011;53(4):1182–91.CrossRefPubMed Ronot M, Bahrami S, Calderaro J, Valla DC, Bedossa P, Belghiti J, et al. Hepatocellular adenomas: accuracy of magnetic resonance imaging and liver biopsy in subtype classification. Hepatology. 2011;53(4):1182–91.CrossRefPubMed
10.
Zurück zum Zitat Bieze M, van den Esschert JW, Nio CY, Verheij J, Reitsma JB, Terpstra V, et al. Diagnostic accuracy of MRI in differentiating hepatocellular adenoma from focal nodular hyperplasia: prospective study of the additional value of gadoxetate disodium. AJR Am J Roentgenol. 2012;199(1):26–34.CrossRefPubMed Bieze M, van den Esschert JW, Nio CY, Verheij J, Reitsma JB, Terpstra V, et al. Diagnostic accuracy of MRI in differentiating hepatocellular adenoma from focal nodular hyperplasia: prospective study of the additional value of gadoxetate disodium. AJR Am J Roentgenol. 2012;199(1):26–34.CrossRefPubMed
11.
Zurück zum Zitat Socas L, Zumbado M, Perez-Luzardo O, Ramos A, Perez C, Hernandez JR, et al. Hepatocellular adenomas associated with anabolic androgenic steroid abuse in bodybuilders: a report of two cases and a review of the literature. Br J Sports Med. 2005;39(5):e27.CrossRefPubMedPubMedCentral Socas L, Zumbado M, Perez-Luzardo O, Ramos A, Perez C, Hernandez JR, et al. Hepatocellular adenomas associated with anabolic androgenic steroid abuse in bodybuilders: a report of two cases and a review of the literature. Br J Sports Med. 2005;39(5):e27.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Hardt A, Stippel D, Odenthal M, Holscher AH, Dienes HP, Drebber U. Development of hepatocellular carcinoma associated with anabolic androgenic steroid abuse in a young bodybuilder: a case report. Case Rep Pathol. 2012;2012:195607.PubMedPubMedCentral Hardt A, Stippel D, Odenthal M, Holscher AH, Dienes HP, Drebber U. Development of hepatocellular carcinoma associated with anabolic androgenic steroid abuse in a young bodybuilder: a case report. Case Rep Pathol. 2012;2012:195607.PubMedPubMedCentral
13.
Zurück zum Zitat Kitao A, Matsui O, Yoneda N, Kozaka K, Kobayashi S, Sanada J, et al. Hepatocellular Carcinoma with beta-Catenin Mutation: Imaging and Pathologic Characteristics. Radiology. 2015;275(3):708–17.CrossRefPubMed Kitao A, Matsui O, Yoneda N, Kozaka K, Kobayashi S, Sanada J, et al. Hepatocellular Carcinoma with beta-Catenin Mutation: Imaging and Pathologic Characteristics. Radiology. 2015;275(3):708–17.CrossRefPubMed
14.
Zurück zum Zitat Solbach P, Potthoff A, Raatschen HJ, Soudah B, Lehmann U, Schneider A, et al. Testosterone-receptor positive hepatocellular carcinoma in a 29-year old bodybuilder with a history of anabolic androgenic steroid abuse: a case report. BMC Gastroenterol. 2015;15:60.CrossRefPubMedPubMedCentral Solbach P, Potthoff A, Raatschen HJ, Soudah B, Lehmann U, Schneider A, et al. Testosterone-receptor positive hepatocellular carcinoma in a 29-year old bodybuilder with a history of anabolic androgenic steroid abuse: a case report. BMC Gastroenterol. 2015;15:60.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Kitao A, Matsui O, Yoneda N, Kozaka K, Kobayashi S, Koda W, et al. Hypervascular hepatocellular carcinoma: correlation between biologic features and signal intensity on gadoxetic acid-enhanced MR images. Radiology. 2012;265(3):780–9.CrossRefPubMedPubMedCentral Kitao A, Matsui O, Yoneda N, Kozaka K, Kobayashi S, Koda W, et al. Hypervascular hepatocellular carcinoma: correlation between biologic features and signal intensity on gadoxetic acid-enhanced MR images. Radiology. 2012;265(3):780–9.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Sutherland T, Seale M, Yap K. Part 1: MRI features of focal nodular hyperplasia with an emphasis on hepatobiliary contrast agents. Journal of medical imaging and radiation oncology. 2014;58(1):50–5.CrossRefPubMed Sutherland T, Seale M, Yap K. Part 1: MRI features of focal nodular hyperplasia with an emphasis on hepatobiliary contrast agents. Journal of medical imaging and radiation oncology. 2014;58(1):50–5.CrossRefPubMed
17.
Zurück zum Zitat Mohajer K, Frydrychowicz A, Robbins JB, Loeffler AG, Reed TD, Reeder SB. Characterization of hepatic adenoma and focal nodular hyperplasia with gadoxetic acid. J Magn Reson Imaging. 2012;36(3):686–96.CrossRefPubMedPubMedCentral Mohajer K, Frydrychowicz A, Robbins JB, Loeffler AG, Reed TD, Reeder SB. Characterization of hepatic adenoma and focal nodular hyperplasia with gadoxetic acid. J Magn Reson Imaging. 2012;36(3):686–96.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Sarma A, Shaaban AM, Heilbrun ME, Rezvani M. Two cases of near-complete regression of focal nodular hyperplasia of the liver: case reports and review of the literature. Radiology case reports. 2012;7(3). Sarma A, Shaaban AM, Heilbrun ME, Rezvani M. Two cases of near-complete regression of focal nodular hyperplasia of the liver: case reports and review of the literature. Radiology case reports. 2012;7(3).
19.
Zurück zum Zitat Mathieu D, Kobeiter H, Cherqui D, Rahmouni A, Dhumeaux D. Oral contraceptive intake in women with focal nodular hyperplasia of the liver. The Lancet. 1998;352(9141):1679–80.CrossRef Mathieu D, Kobeiter H, Cherqui D, Rahmouni A, Dhumeaux D. Oral contraceptive intake in women with focal nodular hyperplasia of the liver. The Lancet. 1998;352(9141):1679–80.CrossRef
20.
Zurück zum Zitat Colli A, Fraquelli M, Massironi S, Colucci A, Paggi S, Conte D. Elective surgery for benign liver tumours. The Cochrane Library. 2007. Colli A, Fraquelli M, Massironi S, Colucci A, Paggi S, Conte D. Elective surgery for benign liver tumours. The Cochrane Library. 2007.
21.
Zurück zum Zitat Mathieu D, Kobeiter H, Maison P, Rahmouni A, Cherqui D, Zafrani ES, et al. Oral contraceptive use and focal nodular hyperplasia of the liver. Gastroenterology. 2000;118(3):560–4.CrossRefPubMed Mathieu D, Kobeiter H, Maison P, Rahmouni A, Cherqui D, Zafrani ES, et al. Oral contraceptive use and focal nodular hyperplasia of the liver. Gastroenterology. 2000;118(3):560–4.CrossRefPubMed
22.
Zurück zum Zitat Anderson SW, Kruskal JB, Kane RA. Benign hepatic tumors and iatrogenic pseudotumors. Radiographics. 2009;29(1):211–29.CrossRefPubMed Anderson SW, Kruskal JB, Kane RA. Benign hepatic tumors and iatrogenic pseudotumors. Radiographics. 2009;29(1):211–29.CrossRefPubMed
23.
Zurück zum Zitat Savastano S, San Bortolo O, Velo E, Rettore C, Altavilla G. Pseudotumoral appearance of peliosis hepatis. AJR Am J Roentgenol. 2005;185(2):558–9.CrossRefPubMed Savastano S, San Bortolo O, Velo E, Rettore C, Altavilla G. Pseudotumoral appearance of peliosis hepatis. AJR Am J Roentgenol. 2005;185(2):558–9.CrossRefPubMed
24.
Zurück zum Zitat Torabi M, Hosseinzadeh K, Federle MP. CT of nonneoplastic hepatic vascular and perfusion disorders. Radiographics. 2008;28(7):1967–82.CrossRefPubMed Torabi M, Hosseinzadeh K, Federle MP. CT of nonneoplastic hepatic vascular and perfusion disorders. Radiographics. 2008;28(7):1967–82.CrossRefPubMed
25.
Zurück zum Zitat Iannaccone R, Federle MP, Brancatelli G, Matsui O, Fishman EK, Narra VR, et al. Peliosis hepatis: spectrum of imaging findings. AJR Am J Roentgenol. 2006;187(1):W43–52.CrossRefPubMed Iannaccone R, Federle MP, Brancatelli G, Matsui O, Fishman EK, Narra VR, et al. Peliosis hepatis: spectrum of imaging findings. AJR Am J Roentgenol. 2006;187(1):W43–52.CrossRefPubMed
26.
Zurück zum Zitat Verswijvel G, Janssens F, Colla P, Mampaey S, Verhelst H, Van Eycken P, et al. Peliosis hepatis presenting as a multifocal hepatic pseudotumor: MR findings in two cases. Eur Radiol. 2003;13 Suppl 4:L40–4.CrossRefPubMed Verswijvel G, Janssens F, Colla P, Mampaey S, Verhelst H, Van Eycken P, et al. Peliosis hepatis presenting as a multifocal hepatic pseudotumor: MR findings in two cases. Eur Radiol. 2003;13 Suppl 4:L40–4.CrossRefPubMed
28.
Zurück zum Zitat Kim SH, Lee JM, Kim WH, Han JK, Lee JY, Choi BI. Focal peliosis hepatis as a mimicker of hepatic tumors: radiological-pathological correlation. J Comput Assist Tomogr. 2007;31(1):79–85.CrossRefPubMed Kim SH, Lee JM, Kim WH, Han JK, Lee JY, Choi BI. Focal peliosis hepatis as a mimicker of hepatic tumors: radiological-pathological correlation. J Comput Assist Tomogr. 2007;31(1):79–85.CrossRefPubMed
29.
Zurück zum Zitat Ferrozzi F, Tognini G, Zuccoli G, Cademartiri F, Pavone P. Peliosis hepatis with pseudotumoral and hemorrhagic evolution: CT and MR findings. Abdom Imaging. 2001;26(2):197–9.CrossRefPubMed Ferrozzi F, Tognini G, Zuccoli G, Cademartiri F, Pavone P. Peliosis hepatis with pseudotumoral and hemorrhagic evolution: CT and MR findings. Abdom Imaging. 2001;26(2):197–9.CrossRefPubMed
30.
Zurück zum Zitat Ferral H, Behrens G, Lopera J. Budd-Chiari syndrome. AJR Am J Roentgenol. 2012;199(4):737–45.CrossRefPubMed Ferral H, Behrens G, Lopera J. Budd-Chiari syndrome. AJR Am J Roentgenol. 2012;199(4):737–45.CrossRefPubMed
31.
Zurück zum Zitat Cura M, Haskal Z, Lopera J. Diagnostic and interventional radiology for Budd-Chiari syndrome. Radiographics. 2009;29(3):669–81.CrossRefPubMed Cura M, Haskal Z, Lopera J. Diagnostic and interventional radiology for Budd-Chiari syndrome. Radiographics. 2009;29(3):669–81.CrossRefPubMed
32.
Zurück zum Zitat Brancatelli G, Vilgrain V, Federle MP, Hakime A, Lagalla R, Iannaccone R, et al. Budd-Chiari syndrome: spectrum of imaging findings. AJR Am J Roentgenol. 2007;188(2):W168–76.CrossRefPubMed Brancatelli G, Vilgrain V, Federle MP, Hakime A, Lagalla R, Iannaccone R, et al. Budd-Chiari syndrome: spectrum of imaging findings. AJR Am J Roentgenol. 2007;188(2):W168–76.CrossRefPubMed
33.
Zurück zum Zitat Aronson JK. Meyler's side effects of drugs: the international encyclopedia of adverse drug reactions and interactions: Elsevier; 2015. Aronson JK. Meyler's side effects of drugs: the international encyclopedia of adverse drug reactions and interactions: Elsevier; 2015.
34.
Zurück zum Zitat Erden A. Budd-Chiari syndrome: a review of imaging findings. Eur J Radiol. 2007;61(1):44–56.CrossRefPubMed Erden A. Budd-Chiari syndrome: a review of imaging findings. Eur J Radiol. 2007;61(1):44–56.CrossRefPubMed
35.
Zurück zum Zitat Lee HK, Park SJ, Yi BH, Yeon EK, Kim JH, Hong HS. Portal vein thrombosis: CT features. Abdom Imaging. 2008;33(1):72–9.CrossRefPubMed Lee HK, Park SJ, Yi BH, Yeon EK, Kim JH, Hong HS. Portal vein thrombosis: CT features. Abdom Imaging. 2008;33(1):72–9.CrossRefPubMed
36.
Zurück zum Zitat Mantaka A, Augoustaki A, Kouroumalis EA, Samonakis DN. Portal vein thrombosis in cirrhosis: diagnosis, natural history, and therapeutic challenges. Ann Gastroenterol. 2018;31(3):315–29.PubMedPubMedCentral Mantaka A, Augoustaki A, Kouroumalis EA, Samonakis DN. Portal vein thrombosis in cirrhosis: diagnosis, natural history, and therapeutic challenges. Ann Gastroenterol. 2018;31(3):315–29.PubMedPubMedCentral
37.
Zurück zum Zitat Margini C, Berzigotti A. Portal vein thrombosis: The role of imaging in the clinical setting. Dig Liver Dis. 2017;49(2):113–20.CrossRefPubMed Margini C, Berzigotti A. Portal vein thrombosis: The role of imaging in the clinical setting. Dig Liver Dis. 2017;49(2):113–20.CrossRefPubMed
38.
Zurück zum Zitat Jha RC, Khera SS, Kalaria AD. Portal Vein Thrombosis: Imaging the Spectrum of Disease With an Emphasis on MRI Features. AJR Am J Roentgenol. 2018;211(1):14–24.CrossRefPubMed Jha RC, Khera SS, Kalaria AD. Portal Vein Thrombosis: Imaging the Spectrum of Disease With an Emphasis on MRI Features. AJR Am J Roentgenol. 2018;211(1):14–24.CrossRefPubMed
39.
Zurück zum Zitat Zhou H, Wang YX, Lou HY, Xu XJ, Zhang MM. Hepatic sinusoidal obstruction syndrome caused by herbal medicine: CT and MRI features. Korean J Radiol. 2014;15(2):218–25.CrossRefPubMedPubMedCentral Zhou H, Wang YX, Lou HY, Xu XJ, Zhang MM. Hepatic sinusoidal obstruction syndrome caused by herbal medicine: CT and MRI features. Korean J Radiol. 2014;15(2):218–25.CrossRefPubMedPubMedCentral
40.
Zurück zum Zitat Erturk SM, Mortele KJ, Binkert CA, Glickman JN, Oliva MR, Ros PR, et al. CT features of hepatic venoocclusive disease and hepatic graft-versus-host disease in patients after hematopoietic stem cell transplantation. AJR Am J Roentgenol. 2006;186(6):1497–501.CrossRefPubMed Erturk SM, Mortele KJ, Binkert CA, Glickman JN, Oliva MR, Ros PR, et al. CT features of hepatic venoocclusive disease and hepatic graft-versus-host disease in patients after hematopoietic stem cell transplantation. AJR Am J Roentgenol. 2006;186(6):1497–501.CrossRefPubMed
41.
Zurück zum Zitat Mortele KJ, Van Vlierberghe H, Wiesner W, Ros PR. Hepatic veno-occlusive disease: MRI findings. Abdom Imaging. 2002;27(5):523–6.CrossRefPubMed Mortele KJ, Van Vlierberghe H, Wiesner W, Ros PR. Hepatic veno-occlusive disease: MRI findings. Abdom Imaging. 2002;27(5):523–6.CrossRefPubMed
42.
Zurück zum Zitat Yang S, Wu J, Lei S. CT Features of Hepatic Veno-occlusive Disease: A Meta-analysis. Acad Radiol. 2018;25(3):328–37.CrossRefPubMed Yang S, Wu J, Lei S. CT Features of Hepatic Veno-occlusive Disease: A Meta-analysis. Acad Radiol. 2018;25(3):328–37.CrossRefPubMed
43.
Zurück zum Zitat Dumont C, Lambert M, Van Beers BE. MR imaging findings in a patient with hepatic veno-occlusive disease. Acta Gastroenterol Belg. 2004;67(2):236–8.PubMed Dumont C, Lambert M, Van Beers BE. MR imaging findings in a patient with hepatic veno-occlusive disease. Acta Gastroenterol Belg. 2004;67(2):236–8.PubMed
Metadaten
Titel
Hepatic disorders associated with exogenous sex steroids: MR imaging findings
verfasst von
Cathryn L. Hui
Zhen Jiang Lee
Publikationsdatum
06.04.2019
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 7/2019
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-019-01941-4

Weitere Artikel der Ausgabe 7/2019

Abdominal Radiology 7/2019 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.